Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.

MLA

Chen, Shuo, et al. “Role of Glycogen Synthase Kinase-3β Inhibitor AZD1080 in Ovarian Cancer.” Drug Design, Development and Therapy, vol. 10, Mar. 2016, pp. 1225–32. EBSCOhost, https://doi.org/10.2147/DDDT.S102506.

APA

Chen, S., Sun, K.-X., Feng, M.-X., Sang, X.-B., Liu, B.-L., & Zhao, Y. (2016). Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer. Drug Design, Development and Therapy, 10, 1225–1232. https://doi.org/10.2147/DDDT.S102506

Chicago

Chen, Shuo, Kai-Xuan Sun, Miao-Xiao Feng, Xiu-Bo Sang, Bo-Liang Liu, and Yang Zhao. 2016. “Role of Glycogen Synthase Kinase-3β Inhibitor AZD1080 in Ovarian Cancer.” Drug Design, Development and Therapy 10 (March): 1225–32. doi:10.2147/DDDT.S102506.